The determination of coagulation FVIII:C and FIX:C were used to diagnose congenital or acquired factor deficiency states, distinguish dysproteinemias and protein synthesis disorders, and monitor substitution therapy with FVIII and FIX concentrates in hemophilia A or B1, 4, 6, 22, 23. This evidence concerns the gene F8 and complement factor I deficiency.